Xylyx Bio receives $1.125 million from multiple foundations to accelerate clinical translation of bioengineered human organs for life-saving transplantation

Posted on by sHq_LoGiNz

Funding supports translational development of bioengineered human lung grafts for clinical transplantation BROOKLYN, N.Y., April 2, 2025 /PRNewswire/ — Xylyx Bio, Inc., a regenerative medicine company, announced that it has received $1,000,000 from the Richard M. Bartlett Jr. Memorial…

Posted in UncategorizedTagged
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.